Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians and ongoing relationships with patients to improve the patient experience and access to optimal care.
In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital.
End-to-End Solutions for patient centric care from rapid diagnosis through delivery of personalized therapies
For more information please contact our Investor Relations:
OTC Markets OTC Markets link: https://www.otcmarkets.com/stock/GNBT/quote